Click for best price
Tumor Genomics Market Size, Share 2024
Tumor genomics, also known as cancer genomics, is an emerging sub-discipline in genomics, mainly through the high-throughput sequencing technology to associate genes with cancer. Tumor is a disease caused by the accumulation of DNA mutations that leads to an uncontrolled proliferation of cells and the formation of new organisms. The main goal of tumor genomics is to provide new methods for tumor diagnosis, tumor clinical outcome prediction and tumor target treatment by identifying new oncogenes or tumor suppressor genes.
This report aims to provide a comprehensive presentation of the global market for Tumor Genomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Genomics. This report contains market size and forecasts of Tumor Genomics in global, including the following market information:
Global Tumor Genomics Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Tumor Genomics market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Assays and Kits Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Tumor Genomics include Abbott Laboratories, Agilent Technologies, Inc, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Fluidigm Corporation, General Electric Company, Illumina, Inc. and Merck KGaA, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tumor Genomics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tumor Genomics Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Tumor Genomics Market Segment Percentages, by Type, 2023 (%)
Assays and Kits
Instrument
Global Tumor Genomics Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Tumor Genomics Market Segment Percentages, by Application, 2023 (%)
Diagnostics and Monitoring
Drug Discovery and Development
Biomarker Discovery
Global Tumor Genomics Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Tumor Genomics Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tumor Genomics revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Tumor Genomics revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Agilent Technologies, Inc
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd
Fluidigm Corporation
General Electric Company
Illumina, Inc.
Merck KGaA
Myriad Genetics, Inc.
Pacific Biosciences of California, Inc.
PerkinElmer
QIAGEN
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tumor Genomics, market overview.
Chapter 2: Global Tumor Genomics market size in revenue.
Chapter 3: Detailed analysis of Tumor Genomics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tumor Genomics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Tumor Genomics Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
108 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Tumor Genomics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tumor Genomics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tumor Genomics Overall Market Size
2.1 Global Tumor Genomics Market Size: 2023 VS 2030
2.2 Global Tumor Genomics Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tumor Genomics Players in Global Market
3.2 Top Global Tumor Genomics Companies Ranked by Revenue
3.3 Global Tumor Genomics Revenue by Companies
3.4 Top 3 and Top 5 Tumor Genomics Companies in Global Market, by Revenue in 2023
3.5 Global Companies Tumor Genomics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tumor Genomics Players in Global Market
3.6.1 List of Global Tier 1 Tumor Genomics Companies
3.6.2 List of Global Tier 2 and Tier 3 Tumor Genomics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Tumor Genomics Market Size Markets, 2023 & 2030
4.1.2 Assays and Kits
4.1.3 Instrument
4.2 By Type - Global Tumor Genomics Revenue & Forecasts
4.2.1 By Type - Global Tumor Genomics Revenue, 2019-2024
4.2.2 By Type - Global Tumor Genomics Revenue, 2025-2030
4.2.3 By Type - Global Tumor Genomics Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tumor Genomics Market Size, 2023 & 2030
5.1.2 Diagnostics and Monitoring
5.1.3 Drug Discovery and Development
5.1.4 Biomarker Discovery
5.2 By Application - Global Tumor Genomics Revenue & Forecasts
5.2.1 By Application - Global Tumor Genomics Revenue, 2019-2024
5.2.2 By Application - Global Tumor Genomics Revenue, 2025-2030
5.2.3 By Application - Global Tumor Genomics Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Tumor Genomics Market Size, 2023 & 2030
6.2 By Region - Global Tumor Genomics Revenue & Forecasts
6.2.1 By Region - Global Tumor Genomics Revenue, 2019-2024
6.2.2 By Region - Global Tumor Genomics Revenue, 2025-2030
6.2.3 By Region - Global Tumor Genomics Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Tumor Genomics Revenue, 2019-2030
6.3.2 US Tumor Genomics Market Size, 2019-2030
6.3.3 Canada Tumor Genomics Market Size, 2019-2030
6.3.4 Mexico Tumor Genomics Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Tumor Genomics Revenue, 2019-2030
6.4.2 Germany Tumor Genomics Market Size, 2019-2030
6.4.3 France Tumor Genomics Market Size, 2019-2030
6.4.4 U.K. Tumor Genomics Market Size, 2019-2030
6.4.5 Italy Tumor Genomics Market Size, 2019-2030
6.4.6 Russia Tumor Genomics Market Size, 2019-2030
6.4.7 Nordic Countries Tumor Genomics Market Size, 2019-2030
6.4.8 Benelux Tumor Genomics Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Tumor Genomics Revenue, 2019-2030
6.5.2 China Tumor Genomics Market Size, 2019-2030
6.5.3 Japan Tumor Genomics Market Size, 2019-2030
6.5.4 South Korea Tumor Genomics Market Size, 2019-2030
6.5.5 Southeast Asia Tumor Genomics Market Size, 2019-2030
6.5.6 India Tumor Genomics Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Tumor Genomics Revenue, 2019-2030
6.6.2 Brazil Tumor Genomics Market Size, 2019-2030
6.6.3 Argentina Tumor Genomics Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Tumor Genomics Revenue, 2019-2030
6.7.2 Turkey Tumor Genomics Market Size, 2019-2030
6.7.3 Israel Tumor Genomics Market Size, 2019-2030
6.7.4 Saudi Arabia Tumor Genomics Market Size, 2019-2030
6.7.5 UAE Tumor Genomics Market Size, 2019-2030
7 Tumor Genomics Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Tumor Genomics Major Product Offerings
7.1.4 Abbott Laboratories Tumor Genomics Revenue in Global Market (2019-2024)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Agilent Technologies, Inc
7.2.1 Agilent Technologies, Inc Company Summary
7.2.2 Agilent Technologies, Inc Business Overview
7.2.3 Agilent Technologies, Inc Tumor Genomics Major Product Offerings
7.2.4 Agilent Technologies, Inc Tumor Genomics Revenue in Global Market (2019-2024)
7.2.5 Agilent Technologies, Inc Key News & Latest Developments
7.3 Bio-Rad Laboratories, Inc.
7.3.1 Bio-Rad Laboratories, Inc. Company Summary
7.3.2 Bio-Rad Laboratories, Inc. Business Overview
7.3.3 Bio-Rad Laboratories, Inc. Tumor Genomics Major Product Offerings
7.3.4 Bio-Rad Laboratories, Inc. Tumor Genomics Revenue in Global Market (2019-2024)
7.3.5 Bio-Rad Laboratories, Inc. Key News & Latest Developments
7.4 Danaher Corporation
7.4.1 Danaher Corporation Company Summary
7.4.2 Danaher Corporation Business Overview
7.4.3 Danaher Corporation Tumor Genomics Major Product Offerings
7.4.4 Danaher Corporation Tumor Genomics Revenue in Global Market (2019-2024)
7.4.5 Danaher Corporation Key News & Latest Developments
7.5 F. Hoffmann-La Roche Ltd
7.5.1 F. Hoffmann-La Roche Ltd Company Summary
7.5.2 F. Hoffmann-La Roche Ltd Business Overview
7.5.3 F. Hoffmann-La Roche Ltd Tumor Genomics Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd Tumor Genomics Revenue in Global Market (2019-2024)
7.5.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.6 Fluidigm Corporation
7.6.1 Fluidigm Corporation Company Summary
7.6.2 Fluidigm Corporation Business Overview
7.6.3 Fluidigm Corporation Tumor Genomics Major Product Offerings
7.6.4 Fluidigm Corporation Tumor Genomics Revenue in Global Market (2019-2024)
7.6.5 Fluidigm Corporation Key News & Latest Developments
7.7 General Electric Company
7.7.1 General Electric Company Company Summary
7.7.2 General Electric Company Business Overview
7.7.3 General Electric Company Tumor Genomics Major Product Offerings
7.7.4 General Electric Company Tumor Genomics Revenue in Global Market (2019-2024)
7.7.5 General Electric Company Key News & Latest Developments
7.8 Illumina, Inc.
7.8.1 Illumina, Inc. Company Summary
7.8.2 Illumina, Inc. Business Overview
7.8.3 Illumina, Inc. Tumor Genomics Major Product Offerings
7.8.4 Illumina, Inc. Tumor Genomics Revenue in Global Market (2019-2024)
7.8.5 Illumina, Inc. Key News & Latest Developments
7.9 Merck KGaA
7.9.1 Merck KGaA Company Summary
7.9.2 Merck KGaA Business Overview
7.9.3 Merck KGaA Tumor Genomics Major Product Offerings
7.9.4 Merck KGaA Tumor Genomics Revenue in Global Market (2019-2024)
7.9.5 Merck KGaA Key News & Latest Developments
7.10 Myriad Genetics, Inc.
7.10.1 Myriad Genetics, Inc. Company Summary
7.10.2 Myriad Genetics, Inc. Business Overview
7.10.3 Myriad Genetics, Inc. Tumor Genomics Major Product Offerings
7.10.4 Myriad Genetics, Inc. Tumor Genomics Revenue in Global Market (2019-2024)
7.10.5 Myriad Genetics, Inc. Key News & Latest Developments
7.11 Pacific Biosciences of California, Inc.
7.11.1 Pacific Biosciences of California, Inc. Company Summary
7.11.2 Pacific Biosciences of California, Inc. Business Overview
7.11.3 Pacific Biosciences of California, Inc. Tumor Genomics Major Product Offerings
7.11.4 Pacific Biosciences of California, Inc. Tumor Genomics Revenue in Global Market (2019-2024)
7.11.5 Pacific Biosciences of California, Inc. Key News & Latest Developments
7.12 PerkinElmer
7.12.1 PerkinElmer Company Summary
7.12.2 PerkinElmer Business Overview
7.12.3 PerkinElmer Tumor Genomics Major Product Offerings
7.12.4 PerkinElmer Tumor Genomics Revenue in Global Market (2019-2024)
7.12.5 PerkinElmer Key News & Latest Developments
7.13 QIAGEN
7.13.1 QIAGEN Company Summary
7.13.2 QIAGEN Business Overview
7.13.3 QIAGEN Tumor Genomics Major Product Offerings
7.13.4 QIAGEN Tumor Genomics Revenue in Global Market (2019-2024)
7.13.5 QIAGEN Key News & Latest Developments
7.14 Siemens Healthineers AG
7.14.1 Siemens Healthineers AG Company Summary
7.14.2 Siemens Healthineers AG Business Overview
7.14.3 Siemens Healthineers AG Tumor Genomics Major Product Offerings
7.14.4 Siemens Healthineers AG Tumor Genomics Revenue in Global Market (2019-2024)
7.14.5 Siemens Healthineers AG Key News & Latest Developments
7.15 Thermo Fisher Scientific Inc.
7.15.1 Thermo Fisher Scientific Inc. Company Summary
7.15.2 Thermo Fisher Scientific Inc. Business Overview
7.15.3 Thermo Fisher Scientific Inc. Tumor Genomics Major Product Offerings
7.15.4 Thermo Fisher Scientific Inc. Tumor Genomics Revenue in Global Market (2019-2024)
7.15.5 Thermo Fisher Scientific Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Tumor Genomics Market Opportunities & Trends in Global Market
Table 2. Tumor Genomics Market Drivers in Global Market
Table 3. Tumor Genomics Market Restraints in Global Market
Table 4. Key Players of Tumor Genomics in Global Market
Table 5. Top Tumor Genomics Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Tumor Genomics Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Tumor Genomics Revenue Share by Companies, 2019-2024
Table 8. Global Companies Tumor Genomics Product Type
Table 9. List of Global Tier 1 Tumor Genomics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tumor Genomics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Tumor Genomics Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Tumor Genomics Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Tumor Genomics Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Tumor Genomics Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Tumor Genomics Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Tumor Genomics Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Tumor Genomics Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Tumor Genomics Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Tumor Genomics Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Tumor Genomics Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Tumor Genomics Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Tumor Genomics Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Tumor Genomics Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Tumor Genomics Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Tumor Genomics Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Tumor Genomics Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Tumor Genomics Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Tumor Genomics Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Tumor Genomics Revenue, (US$, Mn), 2025-2030
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Tumor Genomics Product Offerings
Table 32. Abbott Laboratories Tumor Genomics Revenue (US$, Mn) & (2019-2024)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Agilent Technologies, Inc Company Summary
Table 35. Agilent Technologies, Inc Tumor Genomics Product Offerings
Table 36. Agilent Technologies, Inc Tumor Genomics Revenue (US$, Mn) & (2019-2024)
Table 37. Agilent Technologies, Inc Key News & Latest Developments
Table 38. Bio-Rad Laboratories, Inc. Company Summary
Table 39. Bio-Rad Laboratories, Inc. Tumor Genomics Product Offerings
Table 40. Bio-Rad Laboratories, Inc. Tumor Genomics Revenue (US$, Mn) & (2019-2024)
Table 41. Bio-Rad Laboratories, Inc. Key News & Latest Developments
Table 42. Danaher Corporation Company Summary
Table 43. Danaher Corporation Tumor Genomics Product Offerings
Table 44. Danaher Corporation Tumor Genomics Revenue (US$, Mn) & (2019-2024)
Table 45. Danaher Corporation Key News & Latest Developments
Table 46. F. Hoffmann-La Roche Ltd Company Summary
Table 47. F. Hoffmann-La Roche Ltd Tumor Genomics Product Offerings
Table 48. F. Hoffmann-La Roche Ltd Tumor Genomics Revenue (US$, Mn) & (2019-2024)
Table 49. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 50. Fluidigm Corporation Company Summary
Table 51. Fluidigm Corporation Tumor Genomics Product Offerings
Table 52. Fluidigm Corporation Tumor Genomics Revenue (US$, Mn) & (2019-2024)
Table 53. Fluidigm Corporation Key News & Latest Developments
Table 54. General Electric Company Company Summary
Table 55. General Electric Company Tumor Genomics Product Offerings
Table 56. General Electric Company Tumor Genomics Revenue (US$, Mn) & (2019-2024)
Table 57. General Electric Company Key News & Latest Developments
Table 58. Illumina, Inc. Company Summary
Table 59. Illumina, Inc. Tumor Genomics Product Offerings
Table 60. Illumina, Inc. Tumor Genomics Revenue (US$, Mn) & (2019-2024)
Table 61. Illumina, Inc. Key News & Latest Developments
Table 62. Merck KGaA Company Summary
Table 63. Merck KGaA Tumor Genomics Product Offerings
Table 64. Merck KGaA Tumor Genomics Revenue (US$, Mn) & (2019-2024)
Table 65. Merck KGaA Key News & Latest Developments
Table 66. Myriad Genetics, Inc. Company Summary
Table 67. Myriad Genetics, Inc. Tumor Genomics Product Offerings
Table 68. Myriad Genetics, Inc. Tumor Genomics Revenue (US$, Mn) & (2019-2024)
Table 69. Myriad Genetics, Inc. Key News & Latest Developments
Table 70. Pacific Biosciences of California, Inc. Company Summary
Table 71. Pacific Biosciences of California, Inc. Tumor Genomics Product Offerings
Table 72. Pacific Biosciences of California, Inc. Tumor Genomics Revenue (US$, Mn) & (2019-2024)
Table 73. Pacific Biosciences of California, Inc. Key News & Latest Developments
Table 74. PerkinElmer Company Summary
Table 75. PerkinElmer Tumor Genomics Product Offerings
Table 76. PerkinElmer Tumor Genomics Revenue (US$, Mn) & (2019-2024)
Table 77. PerkinElmer Key News & Latest Developments
Table 78. QIAGEN Company Summary
Table 79. QIAGEN Tumor Genomics Product Offerings
Table 80. QIAGEN Tumor Genomics Revenue (US$, Mn) & (2019-2024)
Table 81. QIAGEN Key News & Latest Developments
Table 82. Siemens Healthineers AG Company Summary
Table 83. Siemens Healthineers AG Tumor Genomics Product Offerings
Table 84. Siemens Healthineers AG Tumor Genomics Revenue (US$, Mn) & (2019-2024)
Table 85. Siemens Healthineers AG Key News & Latest Developments
Table 86. Thermo Fisher Scientific Inc. Company Summary
Table 87. Thermo Fisher Scientific Inc. Tumor Genomics Product Offerings
Table 88. Thermo Fisher Scientific Inc. Tumor Genomics Revenue (US$, Mn) & (2019-2024)
Table 89. Thermo Fisher Scientific Inc. Key News & Latest Developments
List of Figures
Figure 1. Tumor Genomics Segment by Type in 2023
Figure 2. Tumor Genomics Segment by Application in 2023
Figure 3. Global Tumor Genomics Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Tumor Genomics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Tumor Genomics Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tumor Genomics Revenue in 2023
Figure 8. By Type - Global Tumor Genomics Revenue Market Share, 2019-2030
Figure 9. By Application - Global Tumor Genomics Revenue Market Share, 2019-2030
Figure 10. By Type - Global Tumor Genomics Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Tumor Genomics Revenue Market Share, 2019-2030
Figure 12. By Application - Global Tumor Genomics Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Tumor Genomics Revenue Market Share, 2019-2030
Figure 14. By Region - Global Tumor Genomics Revenue Market Share, 2019-2030
Figure 15. By Country - North America Tumor Genomics Revenue Market Share, 2019-2030
Figure 16. US Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Tumor Genomics Revenue Market Share, 2019-2030
Figure 20. Germany Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 21. France Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Tumor Genomics Revenue Market Share, 2019-2030
Figure 28. China Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 32. India Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Tumor Genomics Revenue Market Share, 2019-2030
Figure 34. Brazil Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Tumor Genomics Revenue Market Share, 2019-2030
Figure 37. Turkey Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Tumor Genomics Revenue, (US$, Mn), 2019-2030
Figure 41. Abbott Laboratories Tumor Genomics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Agilent Technologies, Inc Tumor Genomics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Bio-Rad Laboratories, Inc. Tumor Genomics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Danaher Corporation Tumor Genomics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. F. Hoffmann-La Roche Ltd Tumor Genomics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Fluidigm Corporation Tumor Genomics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. General Electric Company Tumor Genomics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Illumina, Inc. Tumor Genomics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Merck KGaA Tumor Genomics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Myriad Genetics, Inc. Tumor Genomics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Pacific Biosciences of California, Inc. Tumor Genomics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. PerkinElmer Tumor Genomics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. QIAGEN Tumor Genomics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Siemens Healthineers AG Tumor Genomics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Thermo Fisher Scientific Inc. Tumor Genomics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
